OTC Markets OTCPK - Delayed Quote
USD
CannaPharmaRX, Inc. (CPMD)
0.0020
-0.0001
(-4.76%)
As of October 30 at 5:00:00 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Constantine Nkafu
|
CEO & Director | 122.46k | -- | 1976 |
|
Mr. Oliver W. Foeste C.A., C.P.A.
|
Chief Financial Officer | 203.73k | -- | 1976 |
CannaPharmaRX, Inc.
4439 Township Rd 304
Mountain View County
Cremona, AB T0M 0R0
Canada
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 26
Description
CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Germany, Israel, Portugal, and Canada. It produces and sells dried cannabis flower and trim shake, as well as unique genetics, medical cannabis, and craft products. The company is based in Cremona, Canada.
Corporate Governance
CannaPharmaRX, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
